Medication info
Labela Tablet 10mg (Rabeprazole Sodium)

Labela Tablet 10mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
PharmGen Science Co., Ltd.
Appearance
Yellowish round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging * 2)
Approval status
Active

MFDS item code 201401471 · Approved 2014.03.28 · Insurance code 670103560

Summary

Main use
Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled, if needed, with on-demand treatment using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, according to the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; a 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this drug for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution, as hepatic function is often reduced.
Child dose
○ Children Safety in children has not been established.

Ingredients

Manufacturer
PharmGen Science Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers. It also alleviates erosive gastritis or ulcer symptoms caused by gastroesophageal reflux disease and can be used for long-term maintenance therapy. For patients with gastrointestinal ulcers accompanied by Helicobacter pylori infection, it is administered in conjunction with antibiotics. It is effective for conditions involving excessive gastric acid secretion, such as Zollinger-Ellison syndrome. Overall, it is used to improve and treat symptoms of various gastrointestinal disorders.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled, if needed, with on-demand treatment using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, according to the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; a 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this drug for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution, as hepatic function is often reduced.

Child dose

○ Children Safety in children has not been established.

Precautions

This medication should not be used in patients with allergies to specific ingredients or who have experienced hypersensitivity reactions. Additionally, women who are pregnant or breastfeeding should not take this medication, and care should be taken when used in conjunction with certain antibiotics. Patients with impaired liver function or elderly patients should use this medication with caution, and those with a history of allergies should also be careful. This medication may cause allergic reactions such as skin rash and itching, and if these symptoms appear, it should be stopped immediately. Regular blood tests and liver function tests should be conducted, and if any abnormalities are found, medical advice should be sought immediately. Symptoms related to the heart or gastrointestinal tract, as well as neurological symptoms, can occur, so careful observation is required if symptoms arise. Long-term use may increase the risk of fractures, so regular check-ups may be necessary. This medication can suppress gastric acid secretion and increase the risk of bacterial infections in the stomach, so if diarrhea persists, inform medical personnel. Drowsiness or dizziness may occur when driving or operating machinery, so caution is advised. It may interact with other medications, so be sure to inform medical personnel if you are taking other medications. This medication should not be chewed or crushed and should be swallowed whole in tablet form. Keep out of reach of children and do not transfer to another container if possible. Do not take this medication for extended periods or above the recommended dosage, and stop immediately and consult a professional if abnormal symptoms occur.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, polydipsia, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disorder, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, spasms, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, muscle weakness in limbs, sensory disturbance, decreased grip strength, language confusion, staggering, delusion, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, excessive muscle tone, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucosal syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, difficulty urinating, kidney stones, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, increased triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, malaise, weight gain, visual disturbances, loss of appetite, cervical stiffness, photosensitive reaction, hangover effects, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, cutaneous lupus erythematosus, systemic lupus erythematosus, acute interstitial nephritis, halitosis, xerostomia, elevated intraocular pressure, palpitations, facial edema, flushing, tingling in hands and feet, allergic reaction, chest tightness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.

Appearance and packaging

Appearance

Yellowish round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.